- Conditions
- Atrial Fibrillation
- Interventions
- Pulmonary Vein Isolation
- Procedure
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 145–168
of 225
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- TactiCath SE
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 156 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 14
- States / cities
- Little Rock, Arkansas • La Jolla, California • Redwood City, California + 10 more
- Conditions
- Atrial Fibrillation, Stroke, Valve Disease, Heart, Atrial Septal Defect, Patent Foramen Ovale, Mitral Valve Disease, Tricuspid Valve Disease, Aortic Valve Disease
- Interventions
- ICE Image guidance
- Device
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 155 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 5
- States / cities
- Aurora, Colorado • Chicago, Illinois • Boston, Massachusetts + 2 more
- Conditions
- Atrial Fibrillation
- Interventions
- Interrupted apixaban, Uninterrupted apixaban
- Drug
- Lead sponsor
- Baim Institute for Clinical Research
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 19
- States / cities
- Huntsville, Alabama • Mission Viejo, California • New Haven, Connecticut + 16 more
- Conditions
- Atrial Fibrillation, Heart Failure, Diastolic Heart Failure
- Interventions
- Catheter ablation, Rate or Rhythm control antiarrhythmic drugs for atrial fibrillation, Insertion of CardioMems Hemodynamic monitor, Empiric heart failure drug therapy
- Device · Drug
- Lead sponsor
- Electrophysiology Research Foundation
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 360 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 7
- States / cities
- Flagstaff, Arizona • Jonesboro, Arkansas • Littleton, Colorado + 4 more
- Conditions
- Persistent Atrial Fibrillation, Atrial Fibrillation
- Interventions
- Radiofrequency Ablation
- Device
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 376 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2024
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Los Angeles, California • Orlando, Florida + 9 more
- Conditions
- Recurrent Paroxysmal Atrial Fibrillation Despite Prior Pulmonary Vein Isolation
- Interventions
- Endocardial PVI, Epicardial Posterior Wall Isolation + LAA Exclusion + Endocardial PVI
- Device
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 18 Years to 80 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 1
- States / cities
- Short Hills, New Jersey
- Conditions
- Atrial Fibrillation Chronic, Persistent Atrial Fibrillation
- Interventions
- Cryo or Radiofrequency (RF) Ablation only of Pulmonary Veins, Cryo or RF Ablation of Pulmonary Veins plus Ablation of the PLAW
- Procedure
- Lead sponsor
- Arash Aryana, MD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 110 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Sacramento, California
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Standard Cryoballoon Pulmonary Vein Isolation (PVI), Cryoballoon PVI + Posterior Wall Isolation
- Procedure · Device
- Lead sponsor
- Dignity Health Medical Foundation
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 153 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 11
- States / cities
- Sacramento, California • Fort Collins, Colorado • Washington D.C., District of Columbia + 7 more
- Conditions
- Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
- Interventions
- MFAM
- Device
- Lead sponsor
- Vivek Reddy
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Self- Report Evaluation-Duke Activity Status Index, Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire, Cardiopulmonary exercise test (CPET), Transthoracic echocardiogram, Ambulatory cardiac rhythm assessment, Cardiovascular magnetic resonance (CMR)
- Behavioral · Diagnostic Test
- Lead sponsor
- Virginia Commonwealth University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
- Conditions
- Atrial Fibrillation
- Interventions
- Study arm
- Behavioral
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 184 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Long-standing Persistent Atrial Fibrillation
- Interventions
- Farapulse Catheter System, Low-dose Colchicine
- Device · Drug
- Lead sponsor
- Vivek Reddy
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 275 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 9
- States / cities
- Jonesboro, Arkansas • Ventura, California • Naples, Florida + 5 more
- Conditions
- Atrial Fibrillation, Mitral Valve Insufficiency, Mitral Valve Stenosis
- Interventions
- MVS, Ablation
- Procedure · Device
- Lead sponsor
- Annetine Gelijns
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 260 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2015
- U.S. locations
- 18
- States / cities
- New Haven, Connecticut • Newark, Delaware • Atlanta, Georgia + 14 more
- Conditions
- Atrial Fibrillation (AF)
- Interventions
- discontinue anticoagulation therapy, Anticoagulant drugs, Catheter Ablation
- Behavioral · Drug · Procedure
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Government
- Eligibility
- 18 Years and older
- Enrollment
- 3,160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Atrial Fibrillation
- Interventions
- PVI Plus Catheter Ablation, PVI Alone
- Procedure
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
- Conditions
- Atrial Fibrillation
- Interventions
- propofol, sevoflurane
- Drug
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 135 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2024
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
- Conditions
- Paroxysmal AF
- Interventions
- Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation System
- Device
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 24
- States / cities
- Jonesboro, Arkansas • La Jolla, California • Sacramento, California + 19 more
- Conditions
- Atrial Fibrillation Ablation
- Interventions
- Totally Thoracoscopic Maze
- Procedure
- Lead sponsor
- Cardiopulmonary Research Science and Technology Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 2
- States / cities
- Springfield, Oregon • Dallas, Texas
- Conditions
- Atrial Fibrillation
- Interventions
- Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator
- Device
- Lead sponsor
- Biosense Webster, Inc.
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 276 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 23
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Fountain Valley, California + 20 more
- Conditions
- Atrial Fibrillation, Paroxysmal Arrhythmia
- Interventions
- Catheter Ablation (NAVISTAR® THERMOCOOL® SF Catheter)
- Device
- Lead sponsor
- Biosense Webster, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 511 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 45
- States / cities
- Huntsville, Alabama • Anchorage, Alaska • Phoenix, Arizona + 40 more
- Conditions
- Atrial Fibrillation
- Interventions
- Adenosine, Isoproterenol
- Drug
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 131 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Sphere-9™ Catheter and Affera™ Ablation System
- Device
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 14
- States / cities
- Birmingham, Alabama • Sarasota, Florida • Atlanta, Georgia + 11 more
- Conditions
- Atrial Fibrillation, Maze Procedure, AF, Ablation
- Interventions
- CellFX® nsPFA™ Cardiac Surgery System
- Device
- Lead sponsor
- Pulse Biosciences, Inc.
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 135 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 3
- States / cities
- St. Helena, California • Orlando, Florida • Ann Arbor, Michigan